Stock Earnings

Question 1

Arcus Biosciences Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Arcus Biosciences Incの総資産は$1,150で、純lossは$-283です。

Question 2

RCUSの主要な財務比率は何ですか？

Accepted Answer

Arcus Biosciences Incの流動比率は1.72、純利益率は-109.68、1株当たり売上高は$2.86です。

Question 3

Arcus Biosciences Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Arcus Biosciences Inc largest revenue segment is Immunotherapies, at a revenue of 258,000,000 in the most earnings release.For geography, United States is the primary market for Arcus Biosciences Inc, at a revenue of 258,000,000.

Question 4

Arcus Biosciences Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Arcus Biosciences Incの純lossは$-283です。

Question 5

Arcus Biosciences Incに負債はありますか？

Accepted Answer

yes、Arcus Biosciences Incの負債は665です。

Question 6

Arcus Biosciences Incの発行済株式数は何株ですか？

Accepted Answer

Arcus Biosciences Incの総発行済株式数は92.2株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	240	258	117	112	382	77
Revenue Growth (YoY)	-9%	121%	4%	-71%	396%	413%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	112	120	117	104	72	42
Research & Development	503	448	340	288	256	159
Operating Expenses	615	568	457	392	328	201
Other Non Operating Income (Expenses)	-8	-4	-2	-2	0	--
Pretax Income	-340	-282	-301	-266	54	-122
Income Tax Expense	1	1	6	1	1	--
Net Income	-341	-283	-307	-267	52	-122
Net Income Growth	26%	-8%	15%	-613%	-143%	45%
Shares Outstanding (Diluted)	106.5	90.1	74	72	74	54.8
Shares Change (YoY)	17%	22%	3%	-3%	35%	25%
EPS (Diluted)	-3.2	-3.14	-4.14	-3.71	0.71	-2.24
EPS Growth	8%	-24%	12%	-623%	-132%	16%
Free Cash Flow	-464	-176	-330	432	-282	108
Free Cash Flow Per Share	-4.35	-1.95	-4.45	6	-3.81	1.97
Gross Margin	--	--	--	--	--	--
Operating Margin	-156.25%	-120.15%	-290.59%	-250%	14.13%	-161.03%
Profit Margin	-142.08%	-109.68%	-262.39%	-238.39%	13.61%	-158.44%
Free Cash Flow Margin	-193.33%	-68.21%	-282.05%	385.71%	-73.82%	140.25%
EBITDA	-365	-300	-332	-274	57	-121
EBITDA Margin	-152.08%	-116.27%	-283.76%	-244.64%	14.92%	-157.14%
D&A For EBITDA	10	10	8	6	3	3
EBIT	-375	-310	-340	-280	54	-124
EBIT Margin	-156.25%	-120.15%	-290.59%	-250%	14.13%	-161.03%
Effective Tax Rate	-0.29%	-0.35%	-1.99%	-0.37%	1.85%	--

Arcus Biosciences Inc (RCUS) Price

RCUS Stock Price Chart

RCUS Income

Follow-Up Questions